Bladder Cancer | Tumor

CURE’s bladder cancer page is a go-to resource for oncology news and updates in the world of bladder cancer. Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in bladder cancer.

New Agent Can Improve BCG Response, Quality of Life in Bladder Cancer

September 18th 2021, 3:00pm


The novel drug N-803 boosted response to Bacille Calmette-Guérin therapy in patients with non-muscle invasive bladder cancer, a study showed.

Lack of Smoking Data in Bladder, Kidney and Prostate Cancer Clinical Trials May Affect Patient Outcomes

September 17th 2021, 5:00pm


Clinical trials that are designed to ask patients with bladder, kidney and prostate cancer about their smoking status may help patients better understand what to expect from their treatment based on their smoking habits.

Phase 2 BCG-Unresponsive Bladder Cancer Study Gets the OK to Start Enrollment

September 1st 2021, 9:08pm


Patients with Bacillus Calmette Guérin-unresponsive carcinoma in-situ will be treated at the University of Chicago in a Theralase study.

FDA Expands Indication of Keytruda for Bladder Cancer Subtype

August 31st 2021, 10:48pm


Keytruda is now indicated for the treatment of locally advanced or metastatic urothelial carcinoma, a type of bladder cancer, although an unmet need remains in the treatment of these patients.

FDA’s Recent Approval of Trodelvy Delivers Promising Treatment Option for Metastatic Bladder Cancer

August 23rd 2021, 6:00pm


A recently approved antibody-drug conjugate provides another much-needed treatment choice for patients with locally advanced and metastatic urothelial cancer.

Patient Recruitment Has Begun for Trial Assessing Cosela in Metastatic Bladder Cancer

August 20th 2021, 6:00pm


Preliminary results of the phase 2 trial assessing the safety and efficacy of Cosela with gemcitabine/platinum-based chemotherapy and Bavencio maintenance therapy for metastatic bladder cancer are expected to be released in the second half of 2022.

FDA Approves Opdivo for Adjuvant Treatment in Bladder Cancer

August 20th 2021, 5:27pm


The FDA granted approval to Opdivo as an adjuvant treatment in patients with high-risk urothelial carcinoma.

Bladder Cancer Treatment May Negatively Impact Patients’ Psychosocial Well-being

July 29th 2021, 6:00pm


Intravesical therapy for patients with non-muscle invasive bladder cancer was found to have an impact on patients’ social, emotional and physical health.

Vietnam Veteran Discusses Agent Orange Exposure and Bladder Cancer

July 29th 2021, 3:00pm


In this episode of the “CURE® Talks Cancer” podcast, a cancer survivor who served in the Vietnam War shares the story of his Agent Orange exposure and bladder cancer.

Continuing to Smoke After Bladder Cancer Diagnosis Increases Recurrence Risk

July 20th 2021, 6:00pm


Smoking cigarettes could lead to a four-fold increased risk of recurrence in patients with a previous diagnosis of non-muscle invasive bladder cancer.